Remdesivir Covid 19 Medicine
- All
- News
-
19 States Mapped With Remdesivir Manufacturers For Faster Supply
The centre has mapped manufacturers of the anti-viral drug remdesivir with 19 states that have high Covid case burden. This will ensure smooth and fast delivery of the medicine, the centre said in a statement.
-
Shortage Of Key Covid Drugs Impedes Maharashtra's Coronavirus Fight
Maharashtra continues to face acute shortage of two key medicines being used to treat coronavirus in India - Remdesivir and Tocilizumab injections, both approved by the US FDA for the treatment of COVID-19. With this, relatives of patients getting treatment in private hospitals of Mumbai, Thane and Pune have been left to fend for themselves. Expert...
-
Cipla Set To Undercut Rivals With Generic Remdesivir: Report
Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option, launched by European competitor Mylan this week.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
-
19 States Mapped With Remdesivir Manufacturers For Faster Supply
The centre has mapped manufacturers of the anti-viral drug remdesivir with 19 states that have high Covid case burden. This will ensure smooth and fast delivery of the medicine, the centre said in a statement.
-
Shortage Of Key Covid Drugs Impedes Maharashtra's Coronavirus Fight
Maharashtra continues to face acute shortage of two key medicines being used to treat coronavirus in India - Remdesivir and Tocilizumab injections, both approved by the US FDA for the treatment of COVID-19. With this, relatives of patients getting treatment in private hospitals of Mumbai, Thane and Pune have been left to fend for themselves. Expert...
-
Cipla Set To Undercut Rivals With Generic Remdesivir: Report
Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option, launched by European competitor Mylan this week.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
